Navigation Links
Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322

ntrols its patented PROfusion protein design engine. Adnexus has over 100 issued and pending patent properties relating to Adnectins and PROfusion.

About Adnexus Therapeutics

Adnexus Therapeutics is focused on generating vital medicines through the discovery, development, and commercialization of its broadly applicable new therapeutic class, Adnectins. Adnexus' lead product candidate, CT-322, is in Phase 1 clinical development in oncology in the United States. The company also has a pipeline of other Adnectin products in preclinical research across multiple therapeutic areas. Adnectins are designed and optimized using PROfusion, the company's patented protein design engine that uniquely enables rapid optimization of protein therapeutics. The company is funded by four leading venture capital firms: Atlas Venture, Flagship Ventures, Polaris Venture Partners, and Venrock Associates.

This news release contains certain forward-looking statements that involve risks and uncertainties. Such statements are only predictions and the company's actual results may differ materially from those anticipated in these forward-looking statements. Factors that may cause such differences include the timing of clinical trials, the risk that products that appeared promising in early research and clinical trials do not demonstrate safety or efficacy in clinical trials and the risk that the company will not obtain approval to market its products.

Adnectin(TM), Adnexus(TM) Therapeutics and PROfusion(TM) are trademarks of Adnexus(TM) Therapeutics, Inc. Adnexus(SM) Therapeutics is a service mark of Adnexus(TM) Therapeutics.

For more information, please visit www.adnexustx.com

Contact

Corporate Contacts
Adnexus Therapeutics, Inc.
Katrine Bosley, 781-891-3745
Vice President Business Development
pr@adnexustx.com
or
Media Contacts

'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:8/31/2015)... Aug. 31, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), ... of innovative therapeutics for the treatment of diseases of ... that its BNC101 IND submission has passed review by ... to initiate a Phase 1 clinical trial in patients ... pancreatic cancer prior to 31 December 2015. ...
(Date:8/31/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ... "Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ ... Competitors and Opportunities: 2015 - 2020 Analysis and ... Pain is defined as an unpleasant sensory ... tissue damage. At some point, everyone experiences pain. ...
(Date:8/30/2015)... y LONDRES, August 30, 2015 ... una visión holística de l cuidado ... el trayecto   Royal ... el debut europeo de IntelliSpace Cardiovascular , un ... ofrece sofisticadas herramientas para acceder, analizar y compartir imágenes ...
Breaking Medicine Technology:Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
(Date:8/31/2015)... Chicago, IL (PRWEB) , ... August 31, 2015 ... ... Gynecologic Cancer Awareness Month 2015 in September by sharing the facts about the ... focused on BRCA1 and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Move over ... products for men and barbershops are scrambling to meet it. , Reports published this ... for hairstyles and haircare. But the data also reflects that men are getting more ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a social well-being ... walking app, Walkadoo , by including an in-app step tracker. , Walkadoo is ... person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps a day ...
(Date:8/31/2015)... ... August 31, 2015 , ... Juvent Sports ( http://www.juvent.com ) ... major sports figures who are finding joint pain relief after using their revolutionary Micro-Impact ... tennis player in the world said, “For the first time in over 20 years ...
(Date:8/31/2015)... ... August 31, 2015 , ... According to book reviewer Angie Santangeloon ... Your Life with Cancer is an excellent resource for everyone since one in ... to be helpful in explaining what cancer is in a easy to understand medically ...
Breaking Medicine News(10 mins):Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2
... per 1,000 males in the 0-6 age group - has ... Foundation//, to tackle the practice of female foeticide. ... by the Foundation in collaboration with the United Nations Population ... statewide campaign to make people aware of the long-term repercussions ...
... Center in New York say they have identified four genes that ... genes work together. ,Turning off all four genes at ... or metastasise - a study in mice showed. ... planning clinical trials of drugs known to target two of the ...
... patients with untreated sleep apnea are more likely to die than ... ,The study followed 164 patients with heart failure for more than ... had double the death rate of those patients who did not ... death rate was 24% in contrast to 12% for the 113 ...
... Fertility declining among men of north India. And thanks to tight ... of Medical Sciences// (AIIMS), New Delhi. ,A ten-year study ... fertility, reports say. ,The sperm count of a normal ... ml as against 60 million per ml around 30 years ago. ...
... Reports by the Centers for Disease Control and Prevention say there ... Americans//, with a body mass index of 40 or more. ... increased by 50 percent from 2000 to 2005(twice as fast as ... an increase by 24 percent of overweight people (BMI of ...
... the use of insect cells appeared safe and produced ... promises to be an alternative to using embryonated eggs ... preliminary study. ,"All currently licensed influenza ... hen's eggs. There are several well-recognized disadvantages to the ...
Cached Medicine News:Health News:Genes That Spread Breast Cancer Fast Identified 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 3Health News:Denim Lovers Beware, Fertility Could Be in Danger, Says a New Study 2Health News:Experimental Flu Vaccine Appears Promising in Early Tests 2
... the Sysmex KX-21N is ideal for ... testing. This 3-part differential hematology ... on the reliable, field proven Sysmex ... completely automatic START-UP function and one ...
... family of pacemakers features several of ... devices in today's worldwide pacing market. ... features and diagnostic information, the system ... Affinity pacemakers platform. , ,It ...
... family of pacemakers features several of ... devices in today's worldwide pacing market. ... features and diagnostic information, the system ... Affinity pacemakers platform. , ,It ...
... The Identity pacemaker family, which includes ... clinicians with the most advanced pacemaker ... Suppression algorithm, the first and only ... suppress atrial fibrillation (AF). The AF ...
Medicine Products: